• Info
  • Insider Ownership

Insider Trading & Ownership of ARCH Venture Fund XIII, L.P.

Location
Chicago, IL
Summary
The estimated value of insider holdings of ARCH Venture Fund XIII, L.P. is at least $36,533,382 dollars as of 09 Mar 2026. ARCH Venture Fund XIII, L.P. is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $36.53M.
Signature
ARCH Venture Partners XIII, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
All Insider Reports
All Insider Reports

Notify me when ARCH Venture Fund XIII, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of ARCH Venture Fund XIII, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LYEL Lyell Immunopharma, Inc. 10%+ Owner $36,533,382 +$12,499,985 +52% 06 Mar 2026

Insider Transactions Reported by ARCH Venture Fund XIII, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.